Day One Biopharmaceuticals, Inc. (DAWN) Ownership

$6.57

$0.17 (2.66%)
Last update: 04:00 PM EST
Day's range
$6.46
Day's range
$6.64

Day One Biopharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 05/12/2025 13.70 M $108.64 M   6.31% 13.34%
BLACKROCK, INC. 05/02/2025 6.76 M $53.59 M   9.78% 6.58%
VANGUARD GROUP INC 05/09/2025 5.94 M $47.13 M   1.61% 5.79%
RA CAPITAL MANAGEMENT, L.P. 05/15/2025 5.76 M $45.64 M   0.00% 5.60%
ALYESKA INVESTMENT GROUP, L.P. 05/15/2025 4.06 M $32.19 M   61.60% 3.95%
FRANKLIN RESOURCES INC 05/13/2025 4.02 M $31.87 M   3.49% 3.91%
PICTET ASSET MANAGEMENT HOLDING SA 05/05/2025 3.64 M $28.83 M   4.17% 3.54%
BRAIDWELL LP 05/15/2025 3.54 M $28.05 M   -27.43% 3.44%
ESTUARY CAPITAL MANAGEMENT LP 05/15/2025 3.33 M $26.38 M   -10.49% 3.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 05/15/2025 2.96 M $23.48 M   14.05% 2.88%
STATE STREET CORP 05/15/2025 2.71 M $21.46 M   -12.73% 2.64%
VESTAL POINT CAPITAL, LP 05/15/2025 2.60 M $20.60 M   80.43% 2.53%
POLAR CAPITAL HOLDINGS PLC 05/15/2025 2.35 M $18.64 M   1,170.27% 2.29%
GOLDMAN SACHS GROUP INC 06/27/2025 1.57 M $12.45 M   232.44% 1.53%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 1.54 M $12.22 M   5.30% 1.50%
CITADEL ADVISORS LLC 05/15/2025 1.34 M $10.62 M   119.04% 1.30%
MILLENNIUM MANAGEMENT LLC 05/15/2025 1.32 M $10.47 M   587.19% 1.29%
DIMENSIONAL FUND ADVISORS LP 05/13/2025 1.30 M $10.33 M   40.55% 1.27%
PRICE T ROWE ASSOCIATES INC /MD/ 05/14/2025 1.17 M $9.30 M   -31.24% 1.14%
HUDSON BAY CAPITAL MANAGEMENT LP 05/14/2025 1.15 M $9.12 M   25.03% 1.12%
BANK OF AMERICA CORP /DE/ 05/15/2025 1.05 M $8.30 M   4,997.67% 1.02%
PARKMAN HEALTHCARE PARTNERS LLC 05/15/2025 1.04 M $8.27 M   4.27% 1.02%
MARSHALL WACE, LLP 05/15/2025 887.18 K $7.04 M   -19.18% 0.86%
DAFNA CAPITAL MANAGEMENT LLC 05/15/2025 731.36 K $5.80 M   0.00% 0.71%
MORGAN STANLEY 05/15/2025 709.42 K $5.63 M   -34.33% 0.69%
AQR CAPITAL MANAGEMENT LLC 05/15/2025 618.63 K $4.91 M   601.41% 0.60%
NORTHERN TRUST CORP 05/13/2025 536.00 K $4.25 M   -2.02% 0.52%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 528.15 K $4.19 M   -1.37% 0.51%
ALGERT GLOBAL LLC 05/13/2025 371.38 K $2.95 M   100.00% 0.36%
STONEPINE CAPITAL MANAGEMENT, LLC 05/14/2025 348.82 K $2.77 M   48.43% 0.34%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 348.44 K $2.76 M   42.96% 0.34%
SPHERA FUNDS MANAGEMENT LTD. 05/15/2025 334.99 K $2.66 M   0.00% 0.33%
DEUTSCHE BANK AG\ 05/09/2025 334.52 K $2.65 M   -6.80% 0.33%
KENNEDY CAPITAL MANAGEMENT LLC 05/13/2025 327.69 K $2.60 M   68.99% 0.32%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 05/14/2025 322.88 K $2.56 M   100.00% 0.31%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2025 280.78 K $2.23 M   52.06% 0.27%
FISHER ASSET MANAGEMENT, LLC 05/14/2025 275.21 K $2.18 M   208.76% 0.27%
PARKWOOD LLC 05/15/2025 275.00 K $2.18 M   0.00% 0.27%
BANK OF NEW YORK MELLON CORP 04/29/2025 248.38 K $1.97 M   1.45% 0.24%
WOODLINE PARTNERS LP 05/15/2025 213.15 K $1.69 M   -73.32% 0.21%
TREXQUANT INVESTMENT LP 05/14/2025 204.78 K $1.62 M   132.78% 0.20%
ROYAL BANK OF CANADA 05/15/2025 185.73 K $1.47 M   40.42% 0.18%
CITIGROUP INC 05/12/2025 164.68 K $1.31 M   5.40% 0.16%
BNP PARIBAS ARBITRAGE, SNC 05/14/2025 162.00 K $1.28 M   341.61% 0.16%
BARCLAYS PLC 05/15/2025 155.21 K $1.23 M   9.73% 0.15%
05/12/2025 139.66 K $1.11 M   100.00% 0.14%
HENNION & WALSH ASSET MANAGEMENT, INC. 04/10/2025 137.97 K $1.09 M   13.87% 0.13%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2025 133.64 K $1.06 M   353.71% 0.13%
UBS GROUP AG 05/13/2025 124.18 K $984.72 K   93.34% 0.12%
RAFFERTY ASSET MANAGEMENT, LLC 05/14/2025 119.16 K $944.94 K   -25.25% 0.12%

Day One Biopharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 195 institutional investors and hedge funds held shares of Day One Biopharmaceuticals, Inc.. The most heavily invested institutionals were:

EXCHANGE TRADED CONCEPTS, LLC: 0

Pallas Capital Advisors LLC: 0

FMR LLC: 13.7 M

BlackRock, Inc.: 6.76 M

VANGUARD GROUP INC: 5.94 M

RA CAPITAL MANAGEMENT, L.P.: 5.76 M

83.30% of Day One Biopharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 91.42 M shares in the last 24 months. This purchase volume represents approximately $600.61 M in transactions.